StockData
Viatris Inc logo

Viatris Inc (VTRS) stock

VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/309% below fair value
$20.45−0.29 (-1.40%)

Close on Nov 17, 2026Market cap $23.49BP/E –Yield 2.35%

Viatris total assets

Total assets on the balance sheet at the end of each period.

Viatris's total assets was $35.04B at Jun 30, 2026. For fiscal 2025 it was $37.19B, down 10.4% from the year before. The highest annual figure on record is $61.55B in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.19B-10.4%
FY2024Dec 31, 2024$41.50B-13.0%
FY2023Dec 31, 2023$47.69B-4.7%
FY2022Dec 31, 2022$50.02B-8.8%
FY2021Dec 31, 2021$54.84B-10.9%
FY2020Dec 31, 2020$61.55B+96.9%
FY2019Dec 31, 2019$31.26B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$35.04B-8.8%
Q1 FY2026Mar 31, 2026$36.83B-4.3%
Q4 FY2025Dec 31, 2025$37.19B-10.4%
Q3 FY2025Sep 30, 2025$37.92B-15.3%
Q2 FY2025Jun 30, 2025$38.41B-15.3%
Q1 FY2025Mar 31, 2025$38.47B-18.7%
Q4 FY2024Dec 31, 2024$41.50B-13.0%
Q3 FY2024Sep 30, 2024$44.75B-8.2%
Q2 FY2024Jun 30, 2024$45.33B-6.9%
Q1 FY2024Mar 31, 2024$47.34B-3.9%
Q4 FY2023Dec 31, 2023$47.69B-4.7%
Q3 FY2023Sep 30, 2023$48.74B+0.2%
Q2 FY2023Jun 30, 2023$48.70B-4.8%
Q1 FY2023Mar 31, 2023$49.29B-7.8%
Q4 FY2022Dec 31, 2022$50.02B-8.8%
Q3 FY2022Sep 30, 2022$48.66B-13.2%
Q2 FY2022Jun 30, 2022$51.13B-11.8%
Q1 FY2022Mar 31, 2022$53.47B-9.3%
Q4 FY2021Dec 31, 2021$54.84B-10.9%
Q3 FY2021Sep 30, 2021$56.07B+391.3%
Q2 FY2021Jun 30, 2021$57.98B+408.1%
Q1 FY2021Mar 31, 2021$58.98B–
Q4 FY2020Dec 31, 2020$61.55B+96.9%
Q3 FY2020Sep 30, 2020$11.41B–
Q2 FY2020Jun 30, 2020$11.41B–
Q1 FY2020Mar 31, 2020$0–
Q4 FY2019Dec 31, 2019$31.26B–

More Viatris figures

See a number that looks wrong?